Chronic Fatigue Therapy

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Chronic Fatigue Therapy
Generic name
EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS
Manufacturer
TRP Company
Product type
HUMAN OTC DRUG
SPL set ID
751334b8-f21b-3f94-e053-2a91aa0a9bb9
SPL ID
4604f3de-7763-ddaa-e063-6394a90a78d0
Version
2
Effective date
2025-12-15
Source export date
2026-09-28
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:18:16
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES. • This product is intended to complement, not replace, standard medical treatment. • Initial worsening of symptoms may occur . Stop use Stop use and ask a doctor if: • You experience worsening of symptoms. • Symptoms last longer than 7 days.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.